Table 1: Characteristics of the Study Population

Characteristic Histopathologic Diagnosis (1)
Total n (%) (2)
Negative Pathology n (%) CIN I n (%) CIN II n (%) CIN III n (%) CC n (%)

Age (Years)
< 25 10 (24.4) 20 (35.7) 4 (25.0) 2 (6.1) 2 (14.3) 38 (23.7)
25-44 21 (51.2) 28 (50.0) 10 (62.5) 19 (57.5) 2 (14.3) 80 (50.0)
45-64 10 (24.4) 8 (14.3) 2 (12.5) 12 (36.4) 9 (64.3) 41 (25.7)
>65 0 (0) 0 (0) 0 (0) 0 (0) 1 (7.1) 1 (0.6)

Socioeconomic level (3)
Low 21 (51.2) 29 (51.8) 9 (56.3) 17 (51.5) 7 (50) 83 (51.9)
Medium 18 (43.9) 22 (39.3) 4 (25) 15 (45.5) 7 (50) 66 (41.2)
High 2 (4.9) 5 (8.9) 3 (18.8) 1 (3.0) 0 (0) 11 (6.9)

Age of first intercourse (years)
< 18 20 (48.8) 30 (53.6) 10 (62.5) 13 (39.4) 8 (57.1) 81 (50.6)
18 - 24 20 (48.8) 25 (44.6) 6 (37.5) 20 (60.6) 6 (42.9) 77 (48.1)
25 - 32 1 (2.4) 1 (1.8) 0 (0) 0 (0) 0 (0) 2 (1.3)

No. of sexual partners
1 - 2 27 (65.9) 36 (64.3) 9 (56.3) 25 (75.8) 10 (71.4) 107 (66.9)
3 - 4 11 (26.8) 14 (25.0) 5 (31.3) 4 (12.1) 4 (28.6) 38 (23.7)
5 - 6 2 (4.9) 4 (7.1) 2 (12.5) 3 (9.1) 0 (0) 11 (6.9)
7 + 1 (2.4) 2 (3.6) 0 (0) 1 (3.0) 0 (0) 4 (2.5)

Age at 1st delivery
< 18 10 (27.8) 7 (15.2) 3 (25) 6 (20.7) 4 (28.6) 30 (18.7)
18 - 24 23 (63.9) 30 (65.2) 9 (75) 18 (62.1) 10 (71.4) 90 (56.3)
25 - 32 3 (8.3) 7 (15.2) 0 (0) 5 (17.2) 0 (0) 15 (9.4)
33 + 0 (0) 2 (4.4) 0 (0) 0 (0) 0 (0) 2 (1.3)

No. of Pregnancies
0 5 (12.2) 10 (17.9) 4 (25.0) 4 (12.1) 0 (0) 23 (14.4)
1-2 24 (58.5) 34 (60.7) 7 (43.8) 13 (39.4) 6 (42.9) 84 (52.5)
3-4 10 (24.4) 11 (19.6) 5 (31.3) 13 (39.4) 1 (7.1) 40 (25)
5+ 2 (4.9) 1 (1.79) 0 (0) 3 (9.1) 7 (50.0) 13 (8.1)

Contraceptives (any method)
Yes 14 (34.1) 27 (48.2) 11 (68.8) 12 (36.4) 5 (35.7) 69 (43.1)
No 27 (65.9) 29 (51.8) 5 (31.3) 21 (63.6) 9 (64.3) 91 (56.9)
History of STD
Yes 2 (4.88) 4 (7.14) 1 (6.2) 0 (0) 0 (0) 7 (4.4)
No 39 (95.1) 52 (92.9) 15 (93.8) 33 (100) 14 (100) 153 (95.6)

History of vaginal Infections
Yes 4 (9.8) 9 (16.1) 2 (12.5) 10 (30.3) 5 (35.7) 30 (18.7)
No 37 (90.2) 47 (83.9) 14 (87.5) 23 (69.7) 9 (64.3) 130 (81.3)

Family history of cancer
Cancer (general) 11 (26.8) 15 (26.8) 7 (43.8) 12 (36.4) 5 (35.7) 50 (31.2)
Cervical cancer 3 (7.3) 2 (3.6) 1 (6.2) 3 (9.1) 0 (0) 9 (5.7)
None 27 (65.9) 39 (69.6) 8 (50) 18 (54.5) 9 (64.3) 101(63.1)

(1) Percentages relative to the total number of cases in each group (see Table 2).
(2) Percentages relative to the total number of participants in the study.
(3) According to the criteria of the Colombian the Secretary for District Planning and the National Administrative Department of Statistics (DANE, Decreto 304, 2008).